Obstetrics, Gynecology and Women&#39;s Health - Oncology

AMERICAN CANCER SOCIETY, INC

2/1/24 → 1/31/29

Project: Research project

Development and Pilot Testing of a mLearning Intervention to Address Sexual Health Needs of Gynecologic Cancer Survivors

Girard, A., Geller, M. A., Pratt, R. J., Rider, G. N. & Vogel, R.

1/1/24 → 12/31/27

Project: Research project

Ovarian Cancer Precision Medicine Initiative (OCPMI)

Winterhoff, B. J., Henzler, C. & Nelson, A. C.

ADELSON MEDICAL RESEARCH FOUNDATION

10/1/23 → 9/30/24

Project: Research project

Precision medicine for ARID1A-mutated ovarian cancer

Bazzaro, M. & Petersen, A. J.

MN OVARIAN CANCER ALLIANCE

10/1/23 → 9/30/24

Project: Research project

Increasing access to cancer trials in Minnesota (InACT-MN)

Erickson, B. K., Geller, M. A., Greeno, E. W., Kratzke, R. A., Ondrey, F. G., Teoh, D. G. & Yee, D.

9/18/23 → 8/31/28

Project: Research project

Increasing access to cancer trials in Minnesota (InACT-MN)

National Cancer Institute

9/18/23 → 8/31/24

Project: Research project

Northwestern Cancer Prevention Consortium -- Surgical Window of Opportunity Study of Megestrol Acetate Compared with Megestrol Acetate and Metformin for Endometrial Intraepithelial Neoplasia

NORTHWESTERN UNIVERSITY, NIH NATIONAL CANCER INSTITUTE (NCI)

8/1/23 → 7/31/24

Project: Research project

Do Cytomegalovirus and Epstein-Barr virus infections exacerbate symptoms of cognitive decline following chemotherapy for ovarian cancer?

Vogel, R. & Geller, M. A.

U.S. DEPARTMENT OF DEFENSE

7/15/23 → 7/14/25

Project: Research project

Examining the associations between cytomegalovirus (CMV), inflammation and 'chemo brain'

Vogel, R.

MN OVARIAN CANCER ALLIANCE

6/1/23 → 5/31/24

Project: Research project

Time toxicity of cancer: the time demands of cancer-related activities and their impact on well-being and quality of life

Vogel, R., Blaes, A. H. & Teoh, D. G.

National Cancer Institute

2/3/23 → 1/31/27

Project: Research project

Time toxicity of cancer: the time demands of cancer-related activities and their impact on well-being and quality of life

Vogel, R. & Wolfson, J.

2/3/23 → 1/31/25

Project: Research project

APOBEC Mutagenesis in Breast Cancer

Harki, D. A., Walters, M. A. & Vogel, R.

UT HEALTH SCIENCE CENTER SAN ANTONIO, NATIONAL INSTITUTES OF HEALTH (NIH)

8/1/22 → 7/31/24

Project: Research project

APOBEC MUTAGENESIS IN BREAST CANCER

Yee, D., Largaespada, D. A., Temiz, N. A. & Vogel, R.

UT HEALTH SCIENCE CENTER SAN ANTONIO, NATIONAL INSTITUTES OF HEALTH (NIH)

8/1/22 → 7/31/24

Project: Research project

Application of engineered tumor infiltrating lymphocytes (TIL) in pediatric osteosarcoma

Webber, B. R., Largaespada, D. A., Moriarity, B. S., Starr, T. & Weigel, B. J.

V FOUNDATION FOR CANCER RESEARCH

7/15/22 → 7/15/25

Project: Research project

GOG Foundation Scholar Investigator award

DAYNAMICA, INC., NATIONAL INSTITUTES OF HEALTH (NIH)

THE GOG FOUNDATION, INC

7/1/22 → 6/30/24

Project: Research project

A Randomized Controlled Trial of Robotic versus Open Radical Hysterectomy for Cervical Cancer(ROCC trial)

Rivard, C.

THE GOG FOUNDATION, INC

6/21/22 → 12/31/26

Project: Research project

App-Assisted Day Reconstruction to Reduce Treatment Burden and Logistic Toxicity in Cancer Patients

Vogel, R. & Blaes, A. H.

6/15/22 → 6/15/24

Project: Research project

A PHASE 1, FIRST IN HUMAN, DOSE-ESCALATION STUDY OF TORL-1-23 IN PARTICIPANTS WITHADVANCED CANCER

TORL BIOTHERAPEUTICS, LLC

4/1/22 → 1/1/26

Project: Research project

UNC-45A uniquely contributes to AD pathology

Bazzaro, M.

ALZHEIMER'S ASSOCIATION

2/1/22 → 1/31/25

Project: Research project

A Phase I Study of HCW9218, a Bifunctional TGF-? Antagonist/IL-15 Protein Complex, in Select Advanced Solid Tumors After Failing at Least Two Prior Therapies

HCW BIOLOGICS, INC

1/21/22 → 1/31/26

Project: Research project

A Phase 3 Randomized, Open-label, Active-comparator Controlled ClinicalStudy of Pembrolizumab versus Platinum Doublet Chemotherapy in Participants WithMismatch Repair Deficient (dMMR) Advanced or Recurrent Endometrial Carcinoma in theFirst-line Settin

THE GOG FOUNDATION, INC, MERCK, SHARP & DOHME LLC

11/2/21 → 11/30/26

Project: Research project

Intra-tumoral activation of antiviral CD8 T cells for tumor immunotherapy

Masopust, D., Geller, M. A. & Vezys, V.

V FOUNDATION FOR CANCER RESEARCH

11/1/21 → 11/1/24

Project: Research project

NRG-GY023: A RANDOMIZED PHASE II TRIAL OF TRIPLET THERAPY (A PD-L1 INHIBITOR DURVALUMAB(MEDI4736) IN COMBINATION WITH OLAPARIB AND CEDIRANIB) COMPARED TO OLAPARIB ANDCEDIRANIB OR DURVALUMAB (MEDI4736) AND CEDIRANIB OR STANDARD OF CARE CHEMOTHERAPYIN W

Teoh, D. G.

NRG ONCOLOGY FOUNDATION, INC., NIH NATIONAL CANCER INSTITUTE (NCI)

10/29/21 → 2/28/25

Project: Research project

Increasing HPV vaccination coverage among adolescent and young adult (AYA) cancer survivors: A multilevel intervention

Teoh, D. G., Melton-Meaux, G. B., Sadak, K. T. & Vogel, R.

U.S. DEPARTMENT OF DEFENSE

8/15/21 → 8/14/25

Project: Research project

A paradigm shift for ovarian cancer biomarkers: Utilizing routine Pap tests as liquid biopsies for the development of targeted mass spectrometry-based proteomic assays for early detection

Skubitz, A. P., Boylan, K. L., Geller, M. A. & Petersen, A. J.

8/5/21 → 7/31/26

Project: Research project

Role of genetic and epigenetic alterations in CFTR in colorectal cancer

Prizment, A. E., Pankratz, N. D., Scott, P. M. & Starr, T.

7/26/21 → 6/30/24

Project: Research project

Reducing cervical cancer screening disparities in Somali immigrant women through a primary case-based HPV self-sampling intervention

Pratt, R. J., Ghebre, R. G., Ramer, T. J. & Yohe, S. L.

6/15/21 → 5/31/26

Project: Research project

A Phase IB/II Multi-Cohort Study of Targeted Agents with Atezolizumab for Patients with Recurrent orPersistent Endometrial Cancer

ALLIANCE FOUNDATION TRIALS, LLC

5/19/21 → 5/31/26

Project: Research project

Phase 1 First-in-Human Study of Leukocyte Immunoglobulin-Like Receptor B2 (LILRB2) Inhibitor Monoclonal Antibody (mAb) JTX-8064, as Monotherapy and in Combination with a Programmed Cell Death Receptor-1 (PD-1) Inhibitor, in Adult Subjectswith Advanced

Teoh, D. G.

JOUNCE THERAPEUTICS, INC

5/1/21 → 4/30/26

Project: Research project

NK cells, their receptors, and cancer therapy

Miller, J. S., Bachanova, V., Basu, S., Brunstein, C. G., Cichocki, F. M., Felices, M., Geller, M. A., Grzywacz, B. J., Le, C. T., Luo, X., Starr, T., Walcheck, B., Warlick, E. D. & Weisdorf, D. J.

4/9/21 → 3/31/26

Project: Research project

Expression of recombinant Fc receptors by engineered NK cells to enhance cancer cell killing

Walcheck, B., Geller, M. A., Miller, J. S., Moriarity, B. S., Rendahl, A., Starr, T. & Wu, J.

4/1/21 → 3/31/26

Project: Research project

A NON-RANDOMIZED PROSPECTIVE CLINICAL TRIAL COMPARING THE NON-INFERIORITY OFSALPINGECTOMY TO SALPINGO-OOPHORECTOMY TO REDUCE THE RISK OF OVARIAN CANCERAMONG BRCA1 CARRIERS [SOROCk]

NRG ONCOLOGY FOUNDATION, INC., NIH NATIONAL CANCER INSTITUTE (NCI)

3/31/21 → 2/28/25

Project: Research project

Manipulating the ovarian cancer tumor microenvironment to enhance natural killer (NK) cell killing

Geller, M. A. & Felices, M.

U.S. DEPARTMENT OF DEFENSE

7/1/20 → 6/30/24

Project: Research project

A Phase 1b, First-in-Human, Dose Escalation and Expansion Study of XMT-1536 In Patients with SolidTumors Likely to Express NaPi2b

MERSANA THERAPEUTICS, INC

4/23/20 → 4/30/25

Project: Research project

Investigation of the role of UNC-45A in Paclitaxel-mediated microtubule stability

Bazzaro, M. & Vogel, R.

NIH NIGMS NATL INST OF GENERAL

8/1/19 → 7/31/24

Project: Research project

The role of cytomegalovirus and inflammation on patient symptoms and outcomes in ovarian cancer

Vogel, R. & Geller, M. A.

US DEPT OF DEFENSE ARMY

7/1/19 → 6/30/24

Project: Research project

NRG Oncology Fixed Price Subaward Master Agreement

NRG ONCOLOGY FOUNDATION, INC., NIH NATIONAL CANCER INSTITUTE (NCI)

3/1/19 → 2/28/25

Project: Research project

A Randomized, Double-Blind, Phase 3 Comparison of Platinum-Based Therapy With TSR-042 and Niraparib Versus Standard of Care Platinum-Based Therapy as First-Line Treatment of Stage III or IV Nonmucinous Epithelial Ovarian Cancer

Teoh, D. G.

TESARO, INC.

9/1/18 → 6/26/26

Project: Research project

Breaking Off Cancer Cell's Addiction to Prevent and Treat Recurrent Ovarian Cancer

Bazzaro, M., Klein, M. E. & Vogel, R.

US DEPT OF DEFENSE ARMY

9/1/17 → 8/31/24

Project: Research project

A phase III multicenter randomized study of atezolizumab

GENENTECH, INC.

6/1/17 → 3/31/25

Project: Research project

A Randomized Phase II/III study of the combination of Ce

NRG ONCOLOGY FOUNDATION, INC.

1/1/17 → 2/28/25

Project: Research project

A Phase III study comparing single-agent olaparib or the

NRG ONCOLOGY FOUNDATION, INC.

10/1/16 → 2/28/25

Project: Research project

Cancer Center Support Grant

Yee, D., Schilz, A. A., Baker, S. A., Bielinsky, A. K., Moriarity, B. S., Weigel, B. J., Carlson, C. S., Lange, C. C. A., Hatsukami, D. K., Downs, L. S., Seelig, D., Falconer, S. N., Felices, M., Harwood, E. M., Nelson, H. H., Hecht, S. S., Hendrickson, E. A., Hirsch, B. A., Joseph, A. M., Julson, S., Poynter, J., Wang, J. J., Kirstein, M. N., Kratzke, R. A., Schwertfeger, K., Beckman, K. B., Largaespada, D. A., Le, C. T., LeBien, T. W., Peterson, L. A., Yamamoto, M. M., Mc Carthy, J. B., Miller, J. S., Geller, M. M. A., O'sullivan, G. M., Ondrey, F. G., Pennell, C. A., Villalta, P. W., Ghebre, R. G., Bouley, R. R., Shimizu, Y., Skubitz, A. P., Sumpmann, M., Griffin, T. J., Turesky, R., Hallstrom, T. C., Wagner, J. E., Wang, J., Fields, G. B., Kersey, J. H., Pirie, P. L., Skubitz, A. P. & Yee, D.

National Cancer Institute

6/1/98 → 1/31/25

Project: Research project

Finished

Single cell analyses of pre- and post-treatment HGSOC to identify therapy resistance mechanisms of persister cells

HARVARD UNIVERSITY, ADELSON MEDICAL RESEARCH FOUNDATION

4/1/23 → 9/30/23

Project: Research project

Mayo Clinic Ovarian Cancer SPORE - Project 4 - Treatment of Advanced Ovarian Cancer Using Gene-Edited CAR NK Cells (Development of a dual CAR Natural Killer cells for ovarian cancer therapy)

Moriarity, B. S. & Starr, T.

MAYO CLINIC ROCHESTER

3/6/23 → 8/31/23

Project: Research project

Spatial Resolved Functional Proteomics Platform

Winterhoff, B. J. & Henzler, C.

OREGON HEALTH & SCIENCE UNIVERSITY, ADELSON MEDICAL RESEARCH FOUNDATION

10/1/22 → 9/30/23

Project: Research project

UCLA AMRF Ovarian Cancer Research Proposal

UNIVERSITY OF CALIFORNIA, LOS ANGEL, ADELSON MEDICAL RESEARCH FOUNDATION

10/1/22 → 9/30/23

Project: Research project

Ovarian Cancer Genome Analysis Platform

JOHNS HOPKINS UNIVERSITY, ADELSON MEDICAL RESEARCH FOUNDATION

10/1/22 → 9/30/23

Project: Research project

Intraperitoneal FT538 with Intravenous Enoblituzumab in Recurrent Ovarian, Fallopian Tube, and PrimaryPeritoneal Cancer